Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2002

View Archived Issues

New data on the safety of drotrecogin alfa (activated) in severe sepsis

Aventis claims novel angiotensin(1-7) receptor agonists for angina pectoris and other disorders

New antiproliferative compounds isolated from fungal species

Modulators of estrogen receptors prepared and tested at GSK

Bayer identifies novel thyroid hormone-like compounds with utility in lipoprotein disorders

Ortho-McNeil claims series of histamine H4 antagonists and their use in asthma

Bayer presents novel p38 inhibitors for COPD

Kowa describes compounds with dual antiplatelet/vasodilating activity

Novel analgesic agents in early development at Gruenenthal

Evotec signs medicinal chemistry optimization agreement with British Biotech

U. of British Columbia and ARC sign license agreement for novel antiinflammatories

NIH grant for development of cyanovirin-N to prevent sexual transmission of HIV

Abbott and Domantis form research collaboration

Helsinn grants CJ Corp. license and distribution rights for palonosetron in Korea

Hyseq and Variagenics to merge

GC-C technology has potential as marker and target for gastric and esophageal cancers

New Novartis program to evaluate once-yearly zoledronic acid in osteoporosis

First approval for new antipsychotic drug granted by FDA

Cardiac isoform-selective inhibitor of adenylyl cyclase presented in Chicago

Novel target to prevent heart attacks and strokes discovered at Lexicon

Potential antiarrhythmic agent that predominantly blocks I(Kur) currents in atrium

ENMD-0995 trial for patients with multiple myeloma under way

AtheroGenics awarded CIHR grant for CART-2 atherosclerosis trial

Enrollment completed for BLP25 liposomal vaccine study in non-small cell lung cancer

Selective p38alpha MAPK inhibitor NPC-31145 improves outcome in glomerulonephritis

SMP-534, an orally active TGF-beta inhibitor, shows promise for diabetic renal disease

Effects of DPC-423 in rabbit model suggest clinical utility in preventing arterial thrombosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...